These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 9563876

  • 1. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 3. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer.
    Gurnani M, Lipari P, Dell J, Shi B, Nielsen LL.
    Cancer Chemother Pharmacol; 1999 Nov; 44(2):143-51. PubMed ID: 10412949
    [Abstract] [Full Text] [Related]

  • 4. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y, Zou YY, Xia WY, Hung MC.
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [Abstract] [Full Text] [Related]

  • 5. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP, Wolf JK, Price JE.
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with SCH58500 (p53 adenovirus) and cyclophosphamide in preclinical cancer models.
    Nielsen LL.
    Oncol Rep; 2000 Oct; 7(6):1191-6. PubMed ID: 11032912
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ.
    Cancer Gene Ther; 1997 Oct; 4(2):129-38. PubMed ID: 9080122
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 9. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
    Kong W, Sun J, Lin C, Zha Y, Lu G, Fu M, Zhang X.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun 18; 37(6):352-5. PubMed ID: 12126571
    [Abstract] [Full Text] [Related]

  • 10. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
    Dong YB, Yang HL, McMasters KM.
    Cancer Gene Ther; 2003 Mar 18; 10(3):168-78. PubMed ID: 12637937
    [Abstract] [Full Text] [Related]

  • 11. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL, Gurnani M, Syed J, Dell J, Hartman B, Cartwright M, Johnson RC.
    Hum Gene Ther; 1998 Mar 20; 9(5):681-94. PubMed ID: 9551616
    [Abstract] [Full Text] [Related]

  • 12. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL.
    Laryngoscope; 2001 Aug 20; 111(8):1459-64. PubMed ID: 11568584
    [Abstract] [Full Text] [Related]

  • 13. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C, Lemmon M, Kirn D.
    Clin Cancer Res; 2000 Dec 20; 6(12):4908-14. PubMed ID: 11156251
    [Abstract] [Full Text] [Related]

  • 14. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.
    Quist SR, Wang-Gohrke S, Köhler T, Kreienberg R, Runnebaum IB.
    Cancer Gene Ther; 2004 Aug 20; 11(8):547-54. PubMed ID: 15153938
    [Abstract] [Full Text] [Related]

  • 15. Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer.
    Kieback DG, Fischer DC, Engehausen DG, Sauerbrei W, Oehler MK, Tong XW, Aguilar-Cordova E.
    Cancer Gene Ther; 2002 May 20; 9(5):478-81. PubMed ID: 11961671
    [Abstract] [Full Text] [Related]

  • 16. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 20; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL, Russell PJ, Knittel T, Milross C.
    Prostate; 2007 Nov 01; 67(15):1630-40. PubMed ID: 17823933
    [Abstract] [Full Text] [Related]

  • 18. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
    Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA, Ji L.
    Clin Cancer Res; 2001 Sep 01; 7(9):2887-97. PubMed ID: 11555607
    [Abstract] [Full Text] [Related]

  • 19. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
    Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N.
    Gynecol Oncol; 2002 Feb 01; 84(2):210-5. PubMed ID: 11812076
    [Abstract] [Full Text] [Related]

  • 20. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO, Gómez-Navarro J, Xiang J, Barnes MN, Mahasreshti P, Alvarez RD, Siegal GP, Badib AO, Buchsbaum D, Curiel DT, Stackhouse MA.
    Mol Ther; 2000 Jun 01; 1(6):545-54. PubMed ID: 10933979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.